Skip to main content

Cursor and Notification Center

The startup is developing therapeutics for drug-resistant cancers — and applying its technology to other arenas, including Covid-19.

Image: MiRecule CEO Anthony Saleh, shown here in 2018, views protein molecules in a silver stained gel. JOANNE S. LAWTON

{iframe}https://www.bizjournals.com/washington/news/2021/05/24/exclusive-mirecule-rna-therapy-cancer-funding.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.